Zenith Capital Corp. (ZHCLF)
OTCMKTS · Delayed Price · Currency is USD
0.0200
0.00 (0.00%)
Aug 18, 2026, 4:00 PM EST
Zenith Capital Revenue
Zenith Capital had revenue of $500.00K in the twelve months ending January 31, 2026. In the fiscal year ending April 30, 2025, Zenith Capital had annual revenue of $500.00K.
Revenue
500.00K
Revenue Growth
n/a
P/S Ratio
6.39
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.19M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 500.00K | - | - |
| Apr 30, 2024 | - | - | - |
| Apr 30, 2023 | - | - | - |
| Apr 30, 2022 | - | - | - |
| Apr 30, 2021 | - | - | - |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| CASI Pharmaceuticals | 20.11M |
| International Stem Cell | 9.51M |
| Pacific Software | 2.40M |
| Vaccinex | 601.00K |
| GPL Holdings | 376.54K |
| Eastgate Biotech | 137.64K |
| Enzolytics | 46.59K |
| VitaSpring Biomedical | -1.49M |